
Initial Offering Price | Underwriting Discount | Proceeds, Before Expenses, to us | ||||||||||
Per Note | Total | Per Note | Total | Per Note | Total | |||||||
5.125% Notes .......... | 99.965% | $749,737,500 | 0.350% | $2,625,000 | 99.615% | $747,112,500 | ||||||
5.300% Notes .......... | 99.954% | $749,655,000 | 0.400% | $3,000,000 | 99.554% | $746,655,000 | ||||||
5.450% Notes .......... | 99.642% | $1,245,525,000 | 0.450% | $5,625,000 | 99.192% | $1,239,900,000 | ||||||
5.900% Notes .......... | 99.860% | $1,248,250,000 | 0.875% | $10,937,500 | 98.985% | $1,237,312,500 | ||||||
Total ....................... | $3,993,167,500 | $22,187,500 | $3,970,980,000 | |||||||||
Citigroup | Deutsche Bank Securities | Goldman Sachs & Co. LLC | HSBC | Morgan Stanley |
BofA Securities | Barclays | BBVA | BNP PARIBAS | RBC Capital Markets |
Bank of China | PNC Capital Markets LLC | Siebert Williams Shank | Standard Chartered Bank | |
Page | |
About This Prospectus Supplement ............................................................................................................ | |
The Company ................................................................................................................................................. | |
Risk Factors .................................................................................................................................................... | |
Summary Consolidated Financial Information ........................................................................................... | |
Capitalization .................................................................................................................................................. | |
Description of the Notes ................................................................................................................................ | |
Certain U.S. Federal Tax Considerations ................................................................................................... | |
Underwriting .................................................................................................................................................... | |
Validity of the Notes ....................................................................................................................................... | |
Incorporation of Certain Information by Reference ................................................................................... | |
Where You Can Find More Information ...................................................................................................... |
Page | |
About This Prospectus .................................................................................................................................. | |
The Company ................................................................................................................................................. | |
Cautionary Note Regarding Forward-Looking Statements ...................................................................... | |
Risk Factors .................................................................................................................................................... | |
Use of Proceeds ............................................................................................................................................. | |
Description of Debt Securities ...................................................................................................................... | |
Plan of Distribution ......................................................................................................................................... | |
Legal Opinions ................................................................................................................................................ | |
Experts ............................................................................................................................................................. | |
Incorporation of Certain Information by Reference ................................................................................... | |
Where You Can Find More Information ...................................................................................................... |
Three Months Ended September 30, | ||||
2026 | 2025 | |||
(Amounts in Millions Except Per Share Amounts) | ||||
NET SALES ........................................................................................................ | $23,276 | $22,386 | ||
Cost of products sold ................................................................................... | 11,678 | 10,887 | ||
Selling, general and administrative expense ............................................ | 5,661 | 5,643 | ||
OPERATING INCOME ..................................................................................... | 5,937 | 5,856 | ||
Interest expense ........................................................................................... | (223) | (197) | ||
Interest income .............................................................................................. | 102 | 108 | ||
Other non-operating income, net ............................................................... | 207 | 268 | ||
EARNINGS BEFORE INCOME TAXES ........................................................ | 6,023 | 6,034 | ||
Income taxes ................................................................................................. | 1,267 | 1,253 | ||
NET EARNINGS ................................................................................................ | 4,757 | 4,781 | ||
Less: Net earnings attributable to noncontrolling interests .................... | 26 | 31 | ||
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE ................. | $4,731 | $4,750 | ||
NET EARNINGS PER COMMON SHARE(1) | ||||
Basic ............................................................................................................... | $2.00 | $2.00 | ||
Diluted ............................................................................................................. | $1.97 | $1.95 | ||
DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING ............................................................................................. | 2,407.2 | 2,436.8 | ||
As of September 30, 2026 | As of June 30, 2026 | |||
(Amounts in Millions) | ||||
WORKING CAPITAL ....................................................................................... | $(12,488) | $(12,486) | ||
TOTAL ASSETS ............................................................................................... | $133,132 | $126,521 | ||
LONG-TERM DEBT ........................................................................................ | $21,897 | $22,842 | ||
TOTAL SHAREHOLDERS’ EQUITY ............................................................ | $55,337 | $54,311 | ||
September 30, 2026 | ||
(In Millions of Dollars Except Per Share Amounts) | ||
Debt: | ||
Debt due within one year (1) ......................................................................................... | $17,028 | |
Long-term debt ................................................................................................................ | 21,897 | |
Total Debt (2) ................................................................................................................... | 38,925 | |
Shareholders’ Equity: | ||
Preferred stock ................................................................................................................ | 747 | |
Common stock, stated value $1 per share; 10,000,000,000 shares authorized, 2,317,783,143 outstanding ................................................................. | 4,009 | |
Additional paid-in capital ............................................................................................... | 69,700 | |
Reserve for Employee Stock Ownership Plan debt retirement ............................... | (555) | |
Accumulated other comprehensive loss ..................................................................... | (12,652) | |
Treasury stock ................................................................................................................. | (144,173) | |
Retained earnings .......................................................................................................... | 138,021 | |
Noncontrolling interest ................................................................................................... | 239 | |
Total Shareholders’ Equity ........................................................................................ | 55,337 | |
Total Capitalization ......................................................................................................... | $94,262 |
Underwriters | Principal Amount of 5.125% Notes | Principal Amount of 5.300% Notes | Principal Amount of 5.450% Notes | Principal Amount of 5.900% Notes | ||||
Citigroup Global Markets Inc. ........................ | $121,875,000 | $121,875,000 | $203,125,000 | $203,125,000 | ||||
Deutsche Bank Securities Inc. ....................... | 106,875,000 | 106,875,000 | 178,125,000 | 178,125,000 | ||||
Goldman Sachs & Co. LLC ............................ | 106,875,000 | 106,875,000 | 178,125,000 | 178,125,000 | ||||
HSBC Securities (USA) Inc. ........................... | 106,875,000 | 106,875,000 | 178,125,000 | 178,125,000 | ||||
Morgan Stanley & Co. LLC ............................ | 106,875,000 | 106,875,000 | 178,125,000 | 178,125,000 | ||||
BofA Securities, Inc. ........................................ | 28,125,000 | 28,125,000 | 46,875,000 | 46,875,000 | ||||
Barclays Capital Inc. ....................................... | 28,125,000 | 28,125,000 | 46,875,000 | 46,875,000 | ||||
BBVA Securities Inc. ....................................... | 28,125,000 | 28,125,000 | 46,875,000 | 46,875,000 | ||||
BNP Paribas Securities Corp. ....................... | 28,125,000 | 28,125,000 | 46,875,000 | 46,875,000 | ||||
RBC Capital Markets, LLC ............................. | 28,125,000 | 28,125,000 | 46,875,000 | 46,875,000 | ||||
Bank of China (Europe) S.A. ......................... | 15,000,000 | 15,000,000 | 25,000,000 | 25,000,000 | ||||
PNC Capital Markets LLC .............................. | 15,000,000 | 15,000,000 | 25,000,000 | 25,000,000 | ||||
Siebert Williams Shank & Co., LLC .............. | 15,000,000 | 15,000,000 | 25,000,000 | 25,000,000 | ||||
Standard Chartered Bank ............................... | 15,000,000 | 15,000,000 | 25,000,000 | 25,000,000 | ||||
Total .............................................................. | $750,000,000 | $750,000,000 | $1,250,000,000 | $1,250,000,000 |
The Procter & Gamble Company | |
Attn: Investor Relations | |
One Procter & Gamble Plaza | |
Cincinnati, Ohio 45202 | |
Telephone: (513) 983-2414 |
Page | |
About This Prospectus .................................................................................................................................. | |
The Company ................................................................................................................................................. | |
Cautionary Note Regarding Forward-Looking Statements ...................................................................... | |
Risk Factors .................................................................................................................................................... | |
Use of Proceeds ............................................................................................................................................. | |
Description of Debt Securities ...................................................................................................................... | |
Plan of Distribution ......................................................................................................................................... | |
Legal Opinions ................................................................................................................................................ | |
Experts ............................................................................................................................................................. | |
Incorporation of Certain Information by Reference ................................................................................... | |
Where You Can Find More Information ...................................................................................................... |
The Procter & Gamble Company | |
Attn: Investor Relations | |
One Procter & Gamble Plaza | |
Cincinnati, Ohio 45202 | |
Telephone: (513) 983-2414 |
